Keyword: Pacific Biosciences
Illumina and PacBio called off their $1.2 billion merger, which has been in the works for over a year, after the FTC described it as "monopolist."
The FTC has moved to block Illumina’s $1.2 billion takeover of Pacific Biosciences, saying the merger would substantially harm competition.
DNA sequencing giant Illumina has agreed to purchase smaller rival Pacific Biosciences for $1.2 billion and tighten its grasp on the market.
The financing equips Oxford Nanopore to scale up its operation as it moves deeper into territory colonized by Illumina and Pacific Biosciences.
Pacific Biosciences and Roche are calling it quits on a product development deal that saw Roche forking over $35 million up front.